EMEA: Draft EudraVigilance access policy for medicines for Veterinary use

EMEA:
Draft EudraVigilance access policy for medicines for Veterinary use. This document should serve as a starting point for the elaboration of EudraVigilance access policies and the subsequent discussion with all relevant stakeholders (National Competent Authorities, Marketing Authorisation Holders, Sponsors of Clinical Trials in the EEA, Healthcare Professionals and the General Public). See also, template for submission of comments.